HAVCR2 and acute myeloid leukemia: Moreover, AML cells accomplish immunological escape by a variety of means, including release of inhibitory cytokines (IL-10, TGF-β), activation of immune checkpoint molecules (PD-L1, TIM3), and downregulation of antigen expression (e.g., HLA deletion).